These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17109639)

  • 1. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV; Sylvester PW
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ; Sylvester PW
    Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S; Sylvester PW
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation.
    Sylvester PW; McIntyre BS; Gapor A; Briski KP
    Cell Prolif; 2001 Dec; 34(6):347-57. PubMed ID: 11736999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
    Sylvester PW; Shah SJ; Samant GV
    J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR; Ayoub NM; Sylvester PW
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    Anticancer Res; 2010 Feb; 30(2):429-37. PubMed ID: 20332450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB; Sylvester PW
    Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P; Tiwari RV; Sylvester PW
    Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis.
    Lahlou H; Müller T; Sanguin-Gendreau V; Birchmeier C; Muller WJ
    Cancer Res; 2012 Jun; 72(12):3080-90. PubMed ID: 22665265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.
    Ayoub NM; Bachawal SV; Sylvester PW
    Cell Prolif; 2011 Dec; 44(6):516-26. PubMed ID: 21973114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG; Dronamraju V; Sylvester PW
    Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
    Wali VB; Bachawal SV; Sylvester PW
    Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells.
    Sylvester PW; Nachnani A; Shah S; Briski KP
    Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S452-9. PubMed ID: 12492634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
    Sylvester PW; Ayoub NM
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.
    Cook RS; Garrett JT; Sánchez V; Stanford JC; Young C; Chakrabarty A; Rinehart C; Zhang Y; Wu Y; Greenberger L; Horak ID; Arteaga CL
    Cancer Res; 2011 Jun; 71(11):3941-51. PubMed ID: 21482676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.